Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor
暂无分享,去创建一个
K. Tedford | T. Sasaki | M. Barbacid | H. Nishina | J. Penninger | I. Kozieradzki | Y. Kong | A. Bernstein | Takehiko Sasaki | L. Marengère | M. Barbacid | K. Fischer | K-D. Fischer | Y-Y. Kong | H. Nishina | K. Tedford | L.E.M. Marengère | I. Kozieradzki | T. Sasaki | M. Starr | G. Chan | S. Gardener | M. P. Nghiem | D. Bouchard | A. Bernstein | J. M. Penninger | G. Chan | M. Nghiem | D. Bouchard | M. Starr | S. Gardener
[1] F. Alt,et al. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction , 1998, Current Biology.
[2] M. White,et al. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. , 1998, Science.
[3] T. Mak,et al. Impaired CD28-mediated Interleukin 2 Production and Proliferation in Stress Kinase SAPK/ERK1 Kinase (SEK1)/Mitogen-activated Protein Kinase Kinase 4 (MKK4)-deficient T Lymphocytes , 1997, The Journal of experimental medicine.
[4] T. Mak,et al. Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells. , 1997, Journal of immunology.
[5] Mark M. Davis,et al. Ligand-specific oligomerization of T-cell receptor molecules , 1997, Nature.
[6] J. Glanz. Force-Carrying Web Pervades Living Cell , 1997, Science.
[7] T. L. Collins,et al. Views on Vav. , 1997, Immunology today.
[8] Michael Loran Dustin,et al. Making the T cell receptor go the distance: a topological view of T cell activation. , 1997, Immunity.
[9] C. Der,et al. Lck regulates Vav activation of members of the Rho family of GTPases , 1997, Molecular and cellular biology.
[10] G. Bokoch,et al. Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells , 1997, Current Biology.
[11] C. S. Chen,et al. Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[12] C. Rudd,et al. Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCR zeta/CD3 induction of interleukin-2. , 1997, Immunity.
[13] T. Mak,et al. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3 , 1997, Nature.
[14] K. Schuebel,et al. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product , 1997, Nature.
[15] C. Monks,et al. Selective modulation of protein kinase C-Θ during T-cell activation , 1997, Nature.
[16] C. Monks,et al. Selective modulation of protein kinase C-theta during T-cell activation. , 1997, Nature.
[17] N. Tapon,et al. Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. , 1997, Current opinion in cell biology.
[18] T. Mustelin,et al. Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. , 1996, Immunity.
[19] M. Olson,et al. Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases , 1996, Current Biology.
[20] J. Chant,et al. Rac and Cdc42 Induce Actin Polymerization and G1 Cell Cycle Progression Independently of p65PAK and the JNK/SAPK MAP Kinase Cascade , 1996, Cell.
[21] David Baltimore,et al. NF-κB: Ten Years After , 1996, Cell.
[22] L. Tuosto,et al. p95vav associates with tyrosine-phosphorylated SLP-76 in antigen- stimulated T cells , 1996, The Journal of experimental medicine.
[23] W. Jy,et al. ASSOCIATION OF MURINE SPLENOCYTE CD3 COMPLEX TO THE CYTOSKELETON: ABSENCE OF MODULATION BY EXOGENOUS FATTY ACIDS , 1996, Cell biology international.
[24] M. Barbacid,et al. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. , 1996, Oncogene.
[25] J. Wu,et al. Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. , 1996, Immunity.
[26] M. Deckert,et al. Endocytosis of GPI-anchored proteins in human lymphocytes: role of glycolipid-based domains, actin cytoskeleton, and protein kinases , 1996, The Journal of cell biology.
[27] T. Roszman,et al. Proteolytic cleavage of alpha-actinin by calpain in T cells stimulated with anti-CD3 monoclonal antibody. , 1996, Journal of immunology.
[28] A. Mondino,et al. Blocked Signal Transduction to the ERK and JNK Protein Kinases in Anergic CD4+ T Cells , 1996, Science.
[29] P. Fields,et al. Blocked Ras Activation in Anergic CD4+ T Cells , 1996, Science.
[30] D. Baltimore,et al. NF-kappa B: ten years after. , 1996, Cell.
[31] B. Malissen,et al. Tyrosine-phosphorylated T cell receptor zeta chain associates with the actin cytoskeleton upon activation of mature T lymphocytes. , 1995, Immunity.
[32] G. Bokoch,et al. Regulation of human leukocyte p21-activated kinases through G protein--coupled receptors. , 1995, Science.
[33] M. Karin,et al. Selective activation of the JNK signaling cascadeand c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs , 1995, Cell.
[34] M. Barbacid,et al. Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+CDS+thymocytes , 1995, Nature.
[35] F. Alt,et al. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene , 1995, Nature.
[36] K. Rajewsky,et al. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav , 1995, Nature.
[37] J. Woodgett,et al. Transforming G Protein-coupled Receptors Potently Activate JNK (SAPK) , 1995, The Journal of Biological Chemistry.
[38] A. Lanzavecchia,et al. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton , 1995, The Journal of experimental medicine.
[39] T. Roszman,et al. cAMP accumulation in T-cells inhibits anti-CD3 monoclonal antibody-induced actin polymerization , 1995, Journal of Neuroimmunology.
[40] M. Barbacid,et al. The vav proto‐oncogene is required early in embryogenesis but not for hematopoietic development in vitro. , 1995, The EMBO journal.
[41] L. Chong,et al. The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells , 1994, Cell.
[42] C. Der,et al. Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras , 1994, Molecular and cellular biology.
[43] Masahiko Hibi,et al. JNK is involved in signal integration during costimulation of T lymphocytes , 1994, Cell.
[44] A. Wittinghofer,et al. Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein , 1994, Molecular and cellular biology.
[45] D E Ingber,et al. Cellular tensegrity: exploring how mechanical changes in the cytoskeleton regulate cell growth, migration, and tissue pattern during morphogenesis. , 1994, International review of cytology.
[46] A. Altman,et al. Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. , 1993, Science.
[47] A. Ullrich,et al. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs , 1992, Nature.
[48] M. Barbacid,et al. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates , 1992, Nature.
[49] M. Barbacid,et al. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. , 1989, The EMBO journal.